TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04770246

TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“The Sponsor had decided to terminate this clinical trial due to an insufficient rate of accrual of patients.”

The sponsor’s own words in the registry.

Life of this trial

2021202220232024Registered2021-02-16Started2021-03-31Primary completion2023-02-28Stopped2023-03-06

Vital statistics

Status
Terminated
Phase
Phase 1
Sponsor
Taiho Oncology, Inc.
Sponsor type
Industry
Conditions
Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations; Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations
Interventions
TAS-117; TAS-117; TAS-117; TAS-117
Participants
17
Sites
8
Countries
Austria, France, United Kingdom, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.